These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9872009)

  • 1. [Importance of recombinant proteins in the adjuvant treatment of cancer].
    Cheron JM
    Ann Pharm Fr; 1998; 56(6):241-3. PubMed ID: 9872009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current role of chemotherapy protectors in cancer treatment.
    Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
    Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future use of hematopoietic growth factors in cancer medicine.
    Mughal TI
    Hematol Oncol; 2004 Sep; 22(3):121-34. PubMed ID: 15991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.
    Satwani P; Bessmertny O; Morris E; Cairo MS
    Curr Hematol Rep; 2003 Nov; 2(6):480-90. PubMed ID: 14561392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors in cancer chemotherapy.
    Crawford J; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of the hematopoietic growth factors.
    Rowland P; Mirro J
    Curr Opin Hematol; 1994 Jul; 1(4):303-9. PubMed ID: 9371297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions with hematopoietic growth factors.
    Vadhan-Raj S
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S96-101. PubMed ID: 19795582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the management of chemotherapy-induced neutropenia.
    Dale DC
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):679-84. PubMed ID: 16258470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant hematopoietic growth factors. Results of molecular cloning and potential therapeutic applications].
    Steinheider G
    Med Klin (Munich); 1991 Apr; 86(4):209-16. PubMed ID: 2056987
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
    Kaye JA
    Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
    Lyman GH; Kuderer NM
    Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer.
    Gunawardana DH; Basser RL; Davis ID; Cebon J; Mitchell P; Underhill C; Kilpatrick TJ; Reardon K; Green MD; Bardy P; Amor P; Crump D; Ng S; Nation RL; Begley CG
    Clin Cancer Res; 2003 Jun; 9(6):2056-65. PubMed ID: 12796368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C; Hast R
    Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematopoietic growth factors. A promising future for use in bone marrow dysfunction.
    Mazza JJ; Reding DJ; Plank GS
    Postgrad Med; 1992 Jun; 91(8):299-302, 305, 309 passim. PubMed ID: 1603758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hematopoietic growth factors on the management of small-cell lung cancer.
    Demetri GD
    Chest; 1993 Apr; 103(4 Suppl):427S-432S. PubMed ID: 8384974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic growth factors and their therapeutic use.
    Wadhwa M; Thorpe R
    Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
    Marsh JC; Ganser A; Stadler M
    Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.